Acknowledgement
This study was supported by grants from the National Research Foundation of Korea (NRF; 2016R1A5A2007009). This research was supported by grant funded by the Ministry of Education (2022R11A1A01072033).
References
- Li GZ, Hu YH, Li DY, Zhang Y, Guo HL, Li YM, Chen F, Xu J. Vincristine-induced peripheral neuropathy: a mini-review. Neurotoxicology 2020; 81: 161-171. https://doi.org/10.1016/j.neuro.2020.10.004
- Ocean AJ, Vahdat LT. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer 2004; 12: 619-625. https://doi.org/10.1007/s00520-004-0657-7
- Geisler S, Doan RA, Strickland A, Huang X, Milbrandt J, DiAntonio A. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice. Brain 2016; 139: 3092-3108. https://doi.org/10.1093/brain/aww251
- Montague K, Simeoli R, Valente J, Malcangio M. A novel interaction between CX3CR1 and CCR2 signalling in monocytes constitutes an underlying mechanism for persistent vincristine-induced pain. J Neuroinflam 2018; 15:101. https://doi.org/10.1186/s12974-018-1116-6
- Fleming JO, Weinstock JV. Clinical trials of helminth therapy in autoimmune diseases: rationale and findings. Parasite Immunol 2015; 37: 277-292. https://doi.org/10.1111/pim.12175
- Helmby H. Human helminth therapy to treat inflammatory disorders- where do we stand? BMC Immunol 2015; 16: 1-5. https://doi.org/10.1111/pim.12810
- Smallwood TB, Giacomin PR, Loukas A, Mulvenna JP, Clark RJ, Miles JJ. Helminth immunomodulation in autoimmune disease. Front Immunol 2017; 8: 453. https://doi.org/10.3389/fimmu.2017.00453
- Maruszewska-Cheruiyot M, Donskow-Lysoniewska K, Doligalska M. Helminth therapy: advances in the use of parasitic worms against Inflammatory Bowel Diseases and its challenges. Helminthol 2018; 55: 1-11. https://doi.org/10.1515/helm-2017-0048
- Shi W, Xu N, Wang X, Vallee I, Liu M, Liu X. Helminth therapy for immune-mediated inflammatory diseases: current and future perspectives. J Inflamm Res 2022; 15: 475-491. https://doi.org/10.2147/JIR.S348079
- Park HK, Cho MK, Choi SH, Kim YS, Yu HS. Trichinella spiralis infection reduces airway allergic inflammation in mice. Exp Parasitol 2011; 127: 539-544. https://doi.org/10.1016/j.exppara.2010
- Cho MK, Park MK, Kang SA, Choi SH, Ahn SC, Yu HS. Trichinella spiralis infection suppressed gut inflammation with CD4+CD25+Foxp3+ T cell recruitment. Korean J Parasitol 2012; 50: 385-390. https://doi.org/10.3347/kjp.2012.50.4.385
- Eissa MM, Mostafa DK, Ghazy AA, El Azzouni MZ, Boulos LM, Younis LK. Anti-arthritic activity of Schistosoma mansoni and Trichinella spiralis derived-antigens in adjuvant arthritis in rats: role of FOXP3+ treg cells. PLoS One. 2016;11: e0165916. https://doi.org/10.1371/journal.pone.0165916
- Gruden-Movsesijan A, Ilic N, Mostarica-Stojkovic M, Stosic-Grujicic S, Milic M, Sofronic-Milosavljevic L. Mechanisms of modulation of experimental autoimmune encephalomyelitis by chronic Trichinella spiralis infection in Dark Agouti rats. Parasite Immunol 2010; 32: 450-459. https://doi.org/10.1111/j.1365-3024.2010.01207.x
- Kang SA, Park MK, Park SK, Choi JH, Lee DI, Song SM, Yu HS. Adoptive transfer of Trichinella spiralis-activated macrophages can ameliorate both Th1- and Th2-activated inflammation in murine models. Sci Rep 2019; 9: 6547. https://doi.org/10.1038/s41598-019-43057-1
- Han C, Yu J, Zhang Z, Zhai P, Zhang Y, Meng S, Yu Y, Li X, Song M. Immunomodulatory effects of Trichinella spiralis excretory-secretory antigens on macrophages. Exp Parasitol 2019; 196: 68-72. https://doi.org/10.1016/j.exppara.2018.10.001
- Kuijk LM, Klaver EJ, Kooij G, van der Pol SM, Heijnen P, Bruijns SC, Kringel H, Pinelli E, Kraal G, de Vries HE, Dijkstra CD, Bouma G, van Die I. Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation. Mol Immunol 2012; 51: 210-218. https://doi.org/10.1016/j.molimm.2012.03.020
- Kang SA, Cho MK, Park MK, Kim DH, Hong YC, Lee YS, Cha HJ, Ock MS, Yu HS. Alteration of helper T-cell related cytokine production in splenocytes during Trichinella spiralis infection. Vet Parasitol 2012; 186: 319-327. https://doi.org/10.1016/j.vetpar.2011.12.002
- Old EA, Nadkarni S, Grist J, Gentry C, Bevan S, Kim KW, Mogg AJ, Perretti M, Malcangio M. Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain. J Clin Invest 2014; 124: 2023-36. https://doi.org/10.1172/JCI71389
- Kang SA, Choi JH, Baek KW, Lee DI, Jeong MJ, Yu HS. Trichinella spiralis infection ameliorated diet-induced obesity model in mice. Int J Parasitol 2021; 51: 63-71. https://doi.org/10.1016/j.ijpara.2020.07.012
- Onkoba N, Chimbari MJ, Kamau JM, Mukaratirwa S. Metabolic and adaptive immune responses induced in mice infected with tissue-dwelling nematode Trichinella zimbabwensis. Open Vet J 2016; 6: 178-184. https://doi.org/10.4314/ovj.v6i3.6
- Martini R, Fischer S, Lopez-Vales R, David S. Interactions between schwann cells and macrophages in injury and inherited demyelinating disease. Glia 2008; 56: 1566-1577. https://doi.org/10.1002/glia.20766
- Kobpornchai P, Flynn RJ, Reamtong O, Rittisoonthorn N, Kosoltanapiwat N, Boonnak K, Boonyuen U, Ampawong S, Jiratanh M, Tattiyapong M, Adisakwattana P. A novel cystatin derived from Trichinella spiralis suppresses macrophage-mediated inflammatory responses. PLoS Negl Trop Dis. 2020; 14: e0008192. https://doi.org/10.1371/journal.pntd.0008192
- Ferreira SH, Lorenzetti BB, Bristow AF, Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988; 334: 698-700. https://doi.org/10.1038/334698a0
- Sommer C, Petrausch S, Lindenlaub T, Toyka K V. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci Lett 1999; 270: 25-28. https://doi.org/10.1016/s0304-3940(99)00450-4
- Carmi Y, Voronov E, Dotan S, Lahat N, Rahat MA, Fogel M, Huszar M, White MR, Dinarello CA, Apte RN. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J Immunol. 2009; 183: 4705-4714. https://doi.org/10.4049/jimmunol.0901511
- Perrin FE, Lacroix S, Aviles-Trigueros M, David S. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1α and interleukin-1β in Wallerian degeneration. Brain 2005; 128: 854-866. https://doi.org/10.1093/brain/awh407
- Rayburn ER, Ezell SJ, Zhang R. Anti-Inflammatory Agents for Cancer Therapy. Mol Cell Pharmacol 2009; 1: 29-43. https://doi.org/10.4255/mcpharmacol.09.05
- Capo V, Despommier DD. Clinical aspects of infection with Trichinella spp. Clin Microbiol Rev 1996; 9: 47-54. https://doi.org/10.1128/CMR.9.1.47